Trademark: 79324763
Word
LINAFEXOR
Status
Registered
Status Code
700
Status Date
Tuesday, June 27, 2023
Serial Number
79324763
Registration Number
7088788
Registration Date
Tuesday, June 27, 2023
Mark Type
4000
Filing Date
Monday, October 11, 2021
Published for Opposition
Tuesday, April 11, 2023

Trademark Owner History
Cascade Pharmaceuticals, Inc - Original Registrant

Classifications
5 Pharmaceutical preparations for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease for medical purposes; organotherapy preparations; enzyme preparations for medical purposes; medicines for the treatment of immune, inflammatory and metabolic diseases, namely, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease, for human purposes; chemical preparations for medical purposes, namely for immune, inflammatory and metabolic diseases, particularly, nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), cholestatic liver disease, inflammatory bowel disease, chronic kidney disease; surgical implants comprised of living tissues; stem cells for medical purposes; biological tissue cultures for medical purposes; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; the foregoing featuring farnesoid X receptor agonists

Trademark Events
Sep 27, 2023
Final Disposition Notice Sent To Ib
Sep 27, 2023
Final Disposition Processed
Sep 27, 2023
Final Disposition Notice Created, To Be Sent To Ib
Jun 27, 2023
Notice Of Registration Confirmation Emailed
Jun 27, 2023
Registered-Principal Register
Apr 24, 2023
Notification Of Possible Opposition - Processed By Ib
Apr 12, 2023
Notification Processed By Ib
Apr 11, 2023
Official Gazette Publication Confirmation E-Mailed
Apr 11, 2023
Published For Opposition
Apr 5, 2023
Notification Of Possible Opposition Sent To Ib
Apr 5, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Mar 22, 2023
Notification Of Possible Opposition Sent To Ib
Mar 22, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 22, 2023
Notification Of Notice Of Publication E-Mailed
Mar 3, 2023
Approved For Pub - Principal Register
Mar 3, 2023
Examiner's Amendment Entered
Mar 3, 2023
Notification Of Examiners Amendment E-Mailed
Mar 3, 2023
Examiners Amendment E-Mailed
Mar 3, 2023
Examiners Amendment -Written
Feb 8, 2023
Teas/Email Correspondence Entered
Feb 7, 2023
Correspondence Received In Law Office
Feb 7, 2023
Teas Response To Office Action Received
Jan 30, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 30, 2023
Teas Change Of Correspondence Received
Jan 30, 2023
Teas Change Of Domestic Representatives Address
Jan 30, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jan 30, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jan 30, 2023
Teas Change Of Owner Address Received
Sep 5, 2022
Refusal Processed By Ib
Aug 15, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Aug 15, 2022
Refusal Processed By Mpu
Jul 26, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Jul 25, 2022
Non-Final Action Written
Jul 15, 2022
Assigned To Examiner
Nov 9, 2021
Application Filing Receipt Mailed
Nov 5, 2021
New Application Office Supplied Data Entered
Nov 4, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24